DVA News and Press, DaVita Inc. From 09/20/22

Summary Pharmaceuticals/biotechnology and healthcare providers are undervalued relative to 11-year averages. Healthcare equipment is the most overpriced subsector. Fast facts on IYH, an alternative to XLV. 10 stock cheaper than their peers in September. This mont...

DaVita Announces Adam H. Schechter to Join its Board of Directors PR Newswire DENVER , Sept. 13, 2022 /PRNewswire/ -- DaVita Inc. announced today that its Board of Directors appointed a new independent director, Adam H. Schechter , to join the Boa...

Summary Glenview Capital Management’s 13F portfolio value decreased from $4.94B to $4B this quarter. The number of positions decreased from 60 to 55. They increased Cigna, Aptiv plc, and Change Healthcare while dropping Bausch Health, Meritor, and AmerisourceBergen. The...

The law firm of Federman & Sherwood has initiated an investigation into DaVita, Inc. [NYSE: DVA] with respect to a data breach. On September 8, 2022, DaVita, Inc., a healthcare company with approximately 2,816 outpatient dialysis centers in the United States, confirmed that the comp...

UBS has upgraded DaVita ( NYSE: DVA ) to buy from neutral citing its ability to deliver EPS growth in the coming years. The firm upped its price target to $117 from $106 (~31% upside based on Thursday's close). Analyst Andrew Mok said he is confident the company can de...

Berkshire Hathaway's 13F stock portfolio value decreased from ~$364B to ~$300B. Their largest three holdings are at ~60% of the entire portfolio. Berkshire Hathaway increased Occidental Petroleum, Ally Financial and Paramount Global while decreasing STORE Capital and General Motor...

Pharmaceutical/biotechnology is the subsector with the highest value and quality scores. Life science tools and healthcare equipment are the most overvalued. Fast facts on IDNA. 10 stocks cheaper than their peers in August. This monthly article series shows a dashboa...

DaVita ( NYSE: DVA ) could benefit significantly if H.R. 8594, the Restore Protections for Dialysis Patients Act, is passed, according to Barclays. The aim of the bill is to restrict health plans from discriminating against patients with end-stage renal disease by offering...

Warren Buffett loves "toll bridge" businesses -- those that offer an essential product or service. DaVita (NYSE: DVA) , which provides life-sustaining renal dialysis, is one such company. That's why Mr. Buffett's company, Berkshire Hathaway, first bought shares back in 2011. Berkshi...

DaVita Inc. (DVA) Q2 2022 Earnings Conference Call August 1, 2022 17:00 ET Corporate Participants Joel Ackerman - Chief Financial Officer and Treasurer Javier Rodriguez - Chief Executive Officer Conference Call Participants Kevin Fischbeck - Bank of Ameri...